Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cardio Diagnostics Holdings Inc. - Common stock (NQ: CDIO ) 0.5209 -0.0291 (-5.29%) Streaming Delayed Price Updated: 2:27 PM EDT, Jul 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Cardio Diagnostics Holdings Inc. - Common stock < Previous 1 2 3 Next > Family Medicine Specialists Selects Cardio Diagnostics’ Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield Patients November 07, 2023 From Cardio Diagnostics Holdings, Inc. Via Business Wire Cardio Diagnostics Leverages AI To Combat Cardiovascular Disease October 31, 2023 By Jeremy Golden, Benzinga Via TheNewswire.com Topics Artificial Intelligence Death Exposures Artificial Intelligence Death Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests – Epi+Gen CHD & PrecisionCHD October 31, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings, Inc and Aimil Ltd Join Forces to Introduce Cardiovascular Epigenetic Technologies to India October 17, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings, Inc Launches New Lab and Fulfillment Center, Paving Way for Expanded Testing Capacity, Reduced Costs, Reduced Turnaround Time and Improved Margins October 12, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in Epigenomics September 20, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings, Inc. and Truckers Health Network Enter Into a Strategic Collaboration to Accelerate Cardiovascular Health Initiatives in the Trucking Industry September 07, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings, Inc Partners with Ascension Borgess Hospital’s Heart Attack Prevention Clinic on Coronary Artery Disease Study September 06, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings, Inc to Participate in Upcoming Investor Conferences September 05, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic Technologies August 18, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings, Inc Announces Expansion of IP Portfolio in Australia with Notice of Allowance of Patent Application August 02, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings, Inc and RiverRock Medical Partner to Bring Epigenetic-Genetic Heart Disease Testing to Austin, Texas July 06, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings, Inc Democratizes CHD Detection with Nationwide Launch of PrecisionCHD™ June 21, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Publishes Research Highlighting the Reversibility of Epigenetic Signatures of Coronary Heart Disease June 13, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings, Inc’s Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management May 16, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Transforming Heart Disease Prevention for Self-Insured Employers in Oklahoma, Missouri, Kansas, and Arkansas: A Strategic Alliance between Connect Clinic and Cardio Diagnostics May 10, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings, Inc Unveils The CardioInnovate360TM BioPharma Research System May 04, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Juniper Research Awards Cardio Diagnostics Holdings, Inc Future Digital Award for Best Digital Diagnostics Solution April 26, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings, Inc to Attend 22nd Annual AHOU Conference April 12, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings, Inc Announces Strategic Engagement with Lifespan.io to Drive Longevity & Heart Disease Research and Education April 05, 2023 From Cardio Diagnostics Via Business Wire Cardio Diagnostics Holdings, Inc Sponsors Becker’s Hospital Review 13th Annual Meeting March 29, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings, Inc Announces Financing Agreement with Yorkville Advisors Global, LP of up to $11.2 Million March 08, 2023 From Cardio Diagnostics Via Business Wire Cardio Diagnostics Holdings, Inc Welcomes Dr. Damon Broyles, MD, as Strategic Advisor for Precision Cardiovascular Medicine Strategy March 08, 2023 From Cardio Diagnostics Holdings, Inc Via Business Wire Cardio Diagnostics Holdings Inc Announces Expansion of IP Portfolio with Notice of Allowance of Patent Application March 02, 2023 From Cardio Diagnostics Holdings Inc Via Business Wire Cardio Diagnostics (NASDAQ: CDIO) Unveils Innovative Blood Test to Detect Early Stages of Coronary Heart Disease February 28, 2023 Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) is engaged as an artificial intelligence-driven precision cardiovascular medicine company, which is focused on Via Spotlight Growth Topics Artificial Intelligence Exposures Artificial Intelligence Cardio Diagnostics Holdings Inc Launches Revolutionary Blood Test for Early Detection of Coronary Heart Disease February 28, 2023 From Cardio Diagnostics Holdings Inc Via Business Wire Cardio Diagnostics Holdings Inc to Debut PrecisionCHD™ at the American College of Cardiology’s 72nd Annual Scientific Session February 22, 2023 From Cardio Diagnostics Holdings Inc Via Business Wire Healing Sanctuary Clinic Partners With Cardio Diagnostics Holdings Inc to Offer the Epi+Gen CHD Test in their Medical Practice in Idaho January 05, 2023 From Cardio Diagnostics Holdings Inc Via Business Wire Cardio Diagnostics Holdings Inc to Attend 41st Annual JP Morgan Healthcare Conference January 04, 2023 From Cardio Diagnostics Holdings Inc Via Business Wire Houston Concierge Medicine Partners With Cardio Diagnostics to Offer the Epi+Gen CHD Test in Their Executive Health Program December 28, 2022 From Cardio Diagnostics Holdings Inc Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.